Interestingly, the percentage of neurons (CTIP2+ plus SATB2+) expressing Fos was modestly higher in grafts at the stroke sites than in control sites, which could reflect greater neuronal integration and activity (Figure 5C). This evidence concerns the gene BCL11B and stroke disorder.